Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06524856 · ClinicalTrials.gov registry record · NA
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
A NA study of Asthma and Chronic Obstructive Pulmonary Disease, sponsored by University of Nebraska.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06524856: Recruiting NA study of Asthma and Chronic Obstructive Pulmonary Disease, sponsored by University of Nebraska.
NCT06524856 is a NA study of Asthma and Chronic Obstructive Pulmonary Disease that is actively recruiting participants, run by University of Nebraska. The registered enrollment target is 20 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06524856, a NA study of Asthma and Chronic Obstructive Pulmonary Disease, is actively recruiting participants, sponsored by University of Nebraska.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators are studying how a device called The Lung Master device can help people breathe better. The investigational device increases the amount of air our lungs can hold, which is important for overall lung health. The Lung Master is not approved by the FDA. The study has two visits approximately one month apart. In the first visit participants will take a spirometry test, particularly forced vital capacity (FVC), to measure volume change in the lungs. Participants will take the investigational device home to use daily, either in the morning or evening. Use will be recorded in a diary. After one month, participants will return for another spirometry test. Each study visit will take about one to two hours to complete.
Primary Outcome
After reaching the end of a normal, quiet expiration, the maximum volume of air that can be inspired will be measured.
Conditions Studied
Interventions
- DEVICE Lung Master (Pulmonary Exerciser)
Study Locations (1)
Nebraska
- Biomechanics Research Building - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2027-03 |
| Phase | NA |
What NCT06524856 shows while recruiting
NCT06524856 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Lung Master (Pulmonary Exerciser) is the first listed.
NCT06524856 reports a single indexed study location in Nebraska.
Frequently Asked Questions
What is clinical trial NCT06524856 about?
NCT06524856 is a clinical study titled "The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)". Investigators are studying how a device called The Lung Master device can help people breathe better. The investigational device increases the amount of air our lungs can hold, which is important for overall lung health. The Lung Master is not approved by the FDA. The study has two visits approxima...
What is the current status of trial NCT06524856?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-10-01. Estimated completion is 2027-03.
What conditions does trial NCT06524856 study?
This clinical trial studies the following conditions: Asthma, Chronic Obstructive Pulmonary Disease, Dyspnea.
What interventions are being tested in trial NCT06524856?
The interventions under investigation include: Lung Master (Pulmonary Exerciser) (DEVICE).
Who is sponsoring clinical trial NCT06524856?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06524856 being conducted?
This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06524856's enrollment target sits among peer trials
20 338th of 374 higher than 30 of 374 other Asthma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Asthma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Automated Inhaler Monitoring for Asthma Medication Usage
RECRUITING · NA
-
Reducing Overuse of Antibiotics With Decision Support
RECRUITING · NA
-
ASTHMAXcel Voice Study
RECRUITING · NA
-
Home Hospital for Suddenly Ill Adults
RECRUITING · NA
-
Asthma and Technology in Emerging African American Adults
RECRUITING · NA
-
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled Asthma
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI